MRI Safe in Patients with Legacy Cardiac Devices

The use of MRI resulted in no long-term clinically significant adverse events in patients with legacy cardiac devices and only 1 in 200 patients experienced a power-on reset of the cardiac device, according to a recent publication in the New England Journal of Medicine. Continue reading

Mortality in PCI Patients With Incomplete Revascularization

In a recent retrospective observational study published in JAMA Cardiology, patients that underwent percutaneous coronary interventions with incomplete revascularization were at higher risk of mortality if they had at least 90% stenosis in an incompletely revascularized vessel, incomplete revascularization in 2 or more vessels, or proximal left anterior descending artery incomplete revascularization. Continue reading

AHA 2017 Wrap-Up in Romanian

Dr. Dragos Vinereanu and Dr. Dan Gaita Present

AHA 2017 Wrap-Up in Hebrew

Dr. Basil Lewis and Dr. Ronen Beeri Present

AHA 2017 Wrap-Up in Japanese

Dr. Hisao Ogawa Presents

AHA 2017 Wrap-Up in French

Dr. Gilles Montalescot and Dr. Mathieu Kerneis Present

AHA 2017 Wrap-Up from a Pacific Rim Perspective

Wrap-Up by Dr. Phil Aylward

AHA 2017 Wrap-Up from the Perspective of the Netherlands

Dr. Freek Verheugt Presents

AHA 2017 Wrap-Up in Arabic

Dr. Chadi Alraies Presents

AHA 2017 Wrap-Up in Portuguese

Dr. Renato Lopes Presents

GM- CSF and Supervised Exercise in PAD

Dr. C. Michael Gibson discusses the trial findings with Dr. Mary McDermott at AHA 2017.

Implementation of Evidence-Based Treatments in NSTEMI Outcomes

Dr. C. Michael Gibson discusses the trial findings with Dr. Karolina Szummer at AHA 2017

Transcatheter Inter-atrial Shunt Device for Treatment of HF

Dr. C. Michael Gibson discusses the trial findings with Dr. Sanjiv Shah at AHA 2017.

Bariatric Surgery in Obese Patients with HTN

Dr. C. Michael Gibson discusses the trial findings with Dr. Carlos Schiavon at AHA 2017

Effects of Exenatide in Type 2 DM and CVD

Dr. C. Michael Gibson discusses the trial findings with Dr. Robert Mentz at AHA 2017

Outcomes with Primary Angioplasty and Prasugrel vs Ticagrelor

Dr. C. Michael Gibson discusses the trial findings with Dr. Zuzana Motovska and Dr. Ota Hlinomaz at AHA 2017

TRICS III – Transfusion Triggers in Cardiac Surgery

Dr. Mathieu Kerneis discusses the trial findings with Dr. David Mazer at AHA 2017

Temporary Neurotoxin Treatment to Prevent Postop AFib

Dr. C. Michael Gibson discusses the trial findings with Dr. Nathan Waldron at AHA 2017

Transcatheter Inter-atrial Shunt Device for Treatment of HF Dr. Sanjiv Shah and Dr. C. Michael Gibson Discuss REDUCE LAP-HF

ALLSTAR: ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration

Dr. Timothy Henry and Dr. C. Michael Gibson Discuss